CVS or DHR: Which Is the Better Value Stock Right Now?

Core Viewpoint - CVS Health is currently viewed as a more attractive option for value investors compared to Danaher based on various valuation metrics and earnings outlook [3][7]. Valuation Metrics - CVS Health has a forward P/E ratio of 9.98, significantly lower than Danaher's forward P/E of 23.97 [5]. - CVS has a PEG ratio of 0.87, while Danaher has a PEG ratio of 2.54, indicating CVS is expected to grow earnings at a more favorable rate relative to its price [5]. - CVS's P/B ratio stands at 1, compared to Danaher's P/B of 2.60, suggesting CVS is more undervalued in terms of its book value [6]. Earnings Outlook - CVS Health has a Zacks Rank of 2 (Buy), indicating an improving earnings outlook, while Danaher holds a Zacks Rank of 3 (Hold) [3][7]. - The positive revisions to CVS's earnings estimates contribute to its favorable position in the Zacks Rank model [3][7]. Value Grades - CVS has received a Value grade of A, while Danaher has a Value grade of D, further supporting the conclusion that CVS is the superior value option at this time [6].